Analystreport

Daré Bioscience, Inc. (NASDAQ: DARE) had its price target raised by analysts at Roth Capital from $11.00 to $17.00.

Dare Bioscience, Inc.  (DARE) 
Last dare bioscience, inc. earnings: 8/14 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.darebioscience.com/investor-relations